Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 9.15447 | 97 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.56295 | 95 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.74181 | 96 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.52978 | 95 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.64042 | 95 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 8.7211 | 96 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 9.3465 | 97 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.68433 | 96 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.83545 | 96 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 8.95811 | 96 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 8.8457 | 96 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.69517 | 95 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 9.00317 | 96 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 9.0085 | 96 |